General principles of pharmaceutical solid polymorphism: a supramolecular perspective.
D002074:Butanones / Q000737:chemistry; D002220:Carbamazepine / Q000737:chemistry; D055598:Chemical Phenomena; D002623:Chemistry Techniques, Analytical / Q000379:methods; D002626:Chemistry, Pharmaceutical; D002627:Chemistry, Physical; D003460:Crystallization / Q000379:methods; D003461:Crystallography; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry; D006801:Humans; D006860:Hydrogen Bonding; D007700:Kinetics; D008958:Models, Molecular; D008968:Molecular Conformation; D015394:Molecular Structure; D000077430:Nabumetone; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D044367:Phase Transition; D012997:Solvents / Q000737:chemistry; D013427:Sulfapyridine / Q000737:chemistry; D013816:Thermodynamics
D002074:Butanones; D005079:Excipients; D004364:Pharmaceutical Preparations; D012997:Solvents; D002220:Carbamazepine; D000077430:Nabumetone; D013427:Sulfapyridine